Pathophysiology
IgG autoantibodies opsonise platelets and megakaryocytes leading to splenic clearance and impaired production; often post-viral in children.
Sources: ASH ITP 2019 (Blood Adv 2019;3:3829); Fostamatinib (Am J Hematol 2018;93:921)
Presentation
Petechiae, purpura, mucosal bleeding (epistaxis, gum), menorrhagia; severe intracranial bleed rare (<1%).
Diagnosis
Isolated thrombocytopenia; normal peripheral smear morphology; exclude drug-induced, TTP, HIV, HCV, H. pylori, lupus. Bone marrow only in atypical adults.
Management
Adults: platelet <30 or bleeding - corticosteroids +/- IVIG; second line: rituximab, TPO-receptor agonists (eltrombopag, romiplostim), fostamatinib, splenectomy. Children usually self-limited.




